Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald N Jones

Showing results (11-20 of 662) with videos related to

Pageof 67
Sort By:
Journal of Clinical Microbiology|December 8, 2005
Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methodsJames E Ross, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North AmericaPaul R Rhomberg, Ronald N Jones,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycinHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 8, 2003
Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinoneTamara R Anderegg, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Fluoroquinolones for the treatment of outpatient community-acquired pneumoniaRonald N Jones, Lionel A Mandell
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000)Kelley A Gordon, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease|February 19, 2013
Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains)Ronald N Jones, Matthew G Stilwell
Expert Review of Anti-Infective Therapy|February 3, 2007
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infectionsHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infectionsMichael A Pfaller, Ronald N Jones
Open Forum Infectious Diseases|March 22, 2019
The Importance of Antimicrobial Resistance Monitoring Worldwide and the Origins of SENTRY Antimicrobial Surveillance ProgramAndrew S Fuhrmeister, Ronald N Jones
Pageof 67

Showing results (11-20 of 662) with videos related to

Sort By:
Pageof 67
Journal of Clinical Microbiology|December 8, 2005
Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methodsJames E Ross, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North AmericaPaul R Rhomberg, Ronald N Jones,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2006
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycinHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 8, 2003
Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinoneTamara R Anderegg, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Fluoroquinolones for the treatment of outpatient community-acquired pneumoniaRonald N Jones, Lionel A Mandell
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000)Kelley A Gordon, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease|February 19, 2013
Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains)Ronald N Jones, Matthew G Stilwell
Expert Review of Anti-Infective Therapy|February 3, 2007
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infectionsHelio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infectionsMichael A Pfaller, Ronald N Jones
Open Forum Infectious Diseases|March 22, 2019
The Importance of Antimicrobial Resistance Monitoring Worldwide and the Origins of SENTRY Antimicrobial Surveillance ProgramAndrew S Fuhrmeister, Ronald N Jones
Pageof 67